Description

MPTP and related compounds can destroy dopamine-containing neurons in the substantia nigra. Patients using a synthetic designer drug designed to be an analogue to meperidine developed a Parkinson-like disorder. MPTP was found as a byproduct of the synthesis.


 

MPTP = 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

 

Oxidation of MPTP by monoamine oxidase (MAO) generates MPP+ that is the actual neurotoxin.

 

Related compounds:

(1) MPP+ = 1-methyl-4-phenylpyridium

(2) MPPP = 1-methyl-4-phenyl-4-propionoxy-piperidine

(3) 2'CH3-MPTP = 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine

 

Clinical features developed after injection of contaminated drug:

(1) immobility

(2) mutism

 

The onset may be just a few hours after the exposure.

 

Patients show an initial clinical response to levodopa but later have frequent adverse reactions to it (dyskinesias, deep "off" states, personality change, other).

 

Some patients have benefited from transplant of fetal dopamine neurons to the substantia nigra.

 


To read more or access our algorithms and calculators, please log in or register.